[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100493921":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":28,"centralContacts":32,"locations":41,"responsibleParty":60,"collaborators":24,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":24,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":24,"enrollmentInfo":71,"targetDuration":24,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":24,"overallStatus":44,"whyStopped":24,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Weill Medical College of Cornell University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Double Voiding","EXPERIMENTAL","The participant will be instructed to void twice.",[13],"Other: Double Voiding",{"label":15,"type":16,"description":17,"interventionNames":18},"Regular Voiding","ACTIVE_COMPARATOR","The participant will be instructed to void normally.",[19],"Other: Regular Voiding",[21,25],{"type":6,"name":9,"description":22,"armGroupLabels":23,"otherNames":24},"Participant will be instructed to void twice.",[9],null,{"type":6,"name":15,"description":26,"armGroupLabels":27,"otherNames":24},"Participant will void as usual",[15],[29],{"name":30,"affiliation":5,"role":31},"Muthukumar Thangamani, M.D.","PRINCIPAL_INVESTIGATOR",[33,37],{"name":30,"role":34,"phone":35,"phoneExt":24,"email":36},"CONTACT","212-746-9074","mut9002@med.cornell.edu",{"name":38,"role":34,"phone":39,"phoneExt":24,"email":40},"Ananda Kimm-Drapeau","212-746-6137","alk4031@med.cornell.edu",[42],{"facility":43,"status":44,"city":45,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Weill Cornell Medical College \u002F NY Presbyterian","RECRUITING","New York","10065","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-74.00597,40.71427,{"lat":53,"lon":52},[56,58,59],{"name":57,"role":34,"phone":35,"phoneExt":24,"email":36},"Thangamani Muthukumar, M.D.",{"name":38,"role":34,"phone":39,"phoneExt":24,"email":40},{"name":57,"role":31,"phone":24,"phoneExt":24,"email":24},{"type":61,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100493921","double-voiding-and-post-transplant-uti-100493921",false,"NCT05711446","Double Voiding and Post-transplant UTI","A Randomized Trial of Double Voiding Versus Usual Voiding to Reduce the Incidence of Urinary Tract Infections in Kidney Transplant Recipients","Inclusion Criteria:\n\n* All adult kidney transplant recipients who undergo routine follow-up at the New York Presbyterian - Weill Cornell Medicine (NYP-WCM) Transplant Clinic.\n\nExclusion Criteria:\n\n* Kidney transplant recipients who are discharged after a transplant with an indwelling catheter (Foley)","ALL","18 Years",{"count":72,"type":73},438,"ESTIMATED","INTERVENTIONAL",[76],"NA","Urinary tract infections (UTI) are common in kidney transplant recipients and are an important cause of illness and hospital admissions. Past studies have shown that about 1 out of 5 of newly transplanted patients develop UTI within their first 3 months of transplantation. Such UTIs increase the risk for blood stream infection and acute rejection of the kidney, Improvements in urinary voiding techniques may reduce the frequency of UTI. The purpose of this study is to evaluate the benefits of \"double voiding\" in kidney transplant recipients.",[79,80],"Urinary Tract Infections","Kidney Transplant; Complications","2026-05-19",{"date":83,"type":84},"2026-05-22","ACTUAL",{"date":86,"type":84},"2023-04-07",{"date":88,"type":73},"2027-05",{"name":5,"class":6},1]